Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Osthole Promote Differentiation and Inhibit Proliferation of Osteoblast by Activating Wnt Signaling and Endoplasmic Reticulum Stress

    Suyang Zheng2, Yong Ma2,3, Yang Guo2, Lining Wang2, Yalan Pan2 Corresponding author

    1. 1Laboratory of New Techniques of Restoration and Reconstruction of Orthopedics and Traumatology, Institute of Traumatology and Orthopedics, Nanjing University of Chinese Medicine, China.
    2. 2Department of Traumatology and Orthopedics, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.

    CORRESPONDENCE

    Suyang Zheng

    Department of Traumatology and Orthopedics, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.

    drguoyang@126.com

    Received: 13-12-2017; Revised: 19-01-2018.

    Volume 14, Issue 58 · pp. 641–646 · PUBLISHED 4 July 2018 · DOI: 10.4103/pm.pm_591_17

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: Osthole is extracted from Fructus Cnidii and is proved to be effective in the treatment of osteoporosis in rats. However, data are still scarce and the mechanism remains elusive. Objective: To investigate the effect of Osthole on proliferation and differentiation of osteoblast. Materials and Methods: Cells were divided into five groups: control group, β‑estradiol group (10−8 M), and Osthole groups (10−6 M, 10−5 M, and 10−4 M). Osteoblast proliferation was evaluated by Cell Counting Kit‑8 (CCK- 8) assay. Alkaline phosphatase (ALP) activity was detected by ALP staining and enzymatic measurement. Mineralization was detected by alizarin‑red staining. The level of osteocalcin was measured by enzyme‑linked immunosorbent assay (ELISA). The expression of key proteins of Wnt/ β‑catenin signaling pathway and endoplasmic reticulum stress (ERS) was analyzed by Western blot. Results: Cell proliferation was retarded in moderate‑dose and high‑dose Osthole group at 1d, 2d and 3d and in low‑dose Osthole group at 1d and 2d (P < 0.05). ALP activity was enhanced in high‑dose Osthole group from 1d to 3d and in moderate‑dose Osthole group at 2d (P < 0.05). Mineralization of bone matrix was promoted in high‑dose Osthole group at 21d (P < 0.05). The secretion of osteocalcin was promoted in Osthole groups at 21d (P < 0.05). Expression of CHOP, GRP78, PDI, Wnt1, and β‑catenin was upregulated in high‑dose Osthole group at 2d, indicating that both of ERS and Wnt/β‑catenin signaling pathway were activated. Conclusion: It can be concluded that the effect of Osthole on inhibition of proliferation is relevant with activation of ERS, and activation of Wnt/β‑catenin signaling pathway is one of the mechanisms how Osthole promotes osteoblast differentiation. In summary, this study provided more evidence for Osthole as a potential anti‑osteoporosis medicine.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Zheng, S., Ma, Y., Guo, Y., Wang, L., & Pan, Y. (2018). Osthole Promote Differentiation and Inhibit Proliferation of Osteoblast by Activating Wnt Signaling and Endoplasmic Reticulum Stress. Pharmacognosy Magazine, 14(58), 641–646. https://doi.org/10.4103/pm.pm_591_17